Dana-Farber Cancer Institute v. Ono Pharmaceutical Co., Ltd.
| BRISTOL-MYERS SQUIBB COMPANY, ONO PHARMACEUTICAL CO., LTD., TASUKU HONJO and E.R. SQUIBB & SONS, L.L.C. |
| DANA-FARBER CANCER INSTITUTE, INC. |
| 19-2050 |
| June 19, 2019 |
| U.S. Court of Appeals, Federal Circuit |
| Other |
Opinions
We have the following opinions for this case:
| Description |
|---|
 Dana-Farber Cancer Institute v. Ono Pharmaceutical Co., Ltd.
|
Docket Report
RSS Track this Docket
This docket was last retrieved on July 22, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 17 **TEXT ONLY** ORDER granting motion to extend time to file brief [ # 16 ] filed by Appellants Bristol-Myers Squibb Company, Ono Pharmaceutical Co., Ltd., Tasuku Honjo and E.R. Squibb & Sons, L.L.C. Appellant's brief is due 09/16/2019. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [622525] [MMA] [Entered: 07/22/2019 01:59 PM] |
| Filing 16 MOTION of Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd. to extend the time to 09/16/2019 to file the Principal Brief. [Consent: unopposed]. Service: 07/22/2019 by email. [622476] [19-2050] [Seth Waxman] [Entered: 07/22/2019 12:01 PM] |
| Filing 15 Docketing Statement for the Appellee Dana-Farber Cancer Institute, Inc.. Service: 07/03/2019 by email. [618903] [19-2050] [Donald Ware] [Entered: 07/03/2019 12:36 PM] |
| Filing 14 Certificate of Interest for Appellee Dana-Farber Cancer Institute, Inc.. Service: 07/03/2019 by email. [618902] [19-2050] [Donald Ware] [Entered: 07/03/2019 12:32 PM] |
| Filing 13 Entry of appearance for Matthew A. Pearson as of counsel for Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 07/03/2019 by email. [618839] [19-2050] [Dianne Elderkin] [Entered: 07/03/2019 10:43 AM] |
| Filing 12 Entry of appearance for Steven D. Maslowski as of counsel for Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 07/03/2019 by email. [618835] [19-2050] [Dianne Elderkin] [Entered: 07/03/2019 10:41 AM] |
| Filing 11 Entry of appearance for Dianne B. Elderkin as of counsel for Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 07/03/2019 by email. [618832] [19-2050] [Dianne Elderkin] [Entered: 07/03/2019 10:38 AM] |
| Filing 10 Docketing Statement for the Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 07/03/2019 by email. [618808] [19-2050] [Seth Waxman] [Entered: 07/03/2019 09:51 AM] |
| Filing 9 Certificate of Interest for Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 07/03/2019 by email. [618806] [19-2050] [Seth Waxman] [Entered: 07/03/2019 09:50 AM] |
| Filing 8 Entry of appearance for Matthew C. Tymann as of counsel for Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 07/03/2019 by email. [618804] [19-2050] [Matthew Tymann] [Entered: 07/03/2019 09:48 AM] |
| Filing 7 Entry of appearance for Steven J. Horn as of counsel for Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 07/03/2019 by email. [618802] [19-2050] [Steven Horn] [Entered: 07/03/2019 09:46 AM] |
| Filing 6 Entry of appearance for Thomas G. Saunders as of counsel for Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 07/03/2019 by email. [618800] [19-2050] [Thomas Saunders] [Entered: 07/03/2019 09:44 AM] |
| Filing 5 Entry of appearance for Seth P. Waxman as principal counsel for Appellants Bristol-Myers Squibb Company, E.R. Squibb & Sons, L.L.C., Tasuku Honjo and Ono Pharmaceutical Co., Ltd.. Service: 07/03/2019 by email. [618798] [19-2050] [Seth Waxman] [Entered: 07/03/2019 09:42 AM] |
| Filing 4 Entry of appearance for Sarah S. Burg as of counsel for Appellee Dana-Farber Cancer Institute, Inc.. Service: 07/02/2019 by email. [618705] [19-2050] [Sarah Burg] [Entered: 07/02/2019 04:52 PM] |
| Filing 3 Entry of appearance for Donald R. Ware as principal counsel for Appellee Dana-Farber Cancer Institute, Inc.. Service: 07/02/2019 by email. [618704] [19-2050] [Donald Ware] [Entered: 07/02/2019 04:48 PM] |
| Filing 2 Entry of appearance for Barbara A. Fiacco as of counsel for Appellee Dana-Farber Cancer Institute, Inc.. Service: 07/02/2019 by email. [618700] [19-2050] [Barbara Fiacco] [Entered: 07/02/2019 04:38 PM] |
| Filing 1 Appeal docketed. Received: 06/18/2019. [615411] Entry of Appearance due 07/03/2019. Certificate of Interest is due on 07/03/2019. Docketing Statement due 07/03/2019. Appellant's brief is due 08/19/2019. [MMA] [Entered: 06/19/2019 10:02 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
